Serum C-reactive protein and procalcitonin kinetics in patients undergoing elective total hip arthroplasty

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Battistelli, Sandra ^a   Fortina, Mattia ^a   Carta, Serafino ^a   Guerranti, Roberto ^a   Nobile, Francesco ^a   Ferrata, Paolo ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; ELECTIVE SURGERY; FEMALE; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HORMONE BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; KINETICS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; BLOOD; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INFLAMMATION; KINETICS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; TIME FACTORS;

EID: 84901783817     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/565080     Document Type: Article

References (31)

1. Pulido L., Ghanem E., Joshi A., Purtill J. J., Parvizi J., Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clinical Orthopaedics and Related Research 2008 466 7 1710 1715 2-s2.0-45849148216 10.1007/s11999-008-0209-4
2. Choong P. F. M., Dowsey M. M., Carr D., Daffy J., Stanley P., Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen. Acta Orthopaedica 2007 78 6 755 765 2-s2.0-38749130096 10.1080/17453670710014527 (Pubitemid 351185596)
3. Phillips J. E., Crane T. P., Noy M., Elliott T. S. J., Grimer R. J., The incidence of deep prosthetic infections in a specialist orthopaedic hospital. A 15-year prospective survey. Journal of Bone and Joint Surgery B 2006 88 7 943 948 2-s2.0-33745951009 10.1302/0301-620X.88B7.17150 (Pubitemid 44057185)
4. Ridker P. M., High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001 103 13 1813 1818 2-s2.0-0035799331 (Pubitemid 32291421)
5. Tsimikas S., Willerson J. T., Ridker P. M., C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. Journal of the American College of Cardiology 2006 47 8 C19 C31 2-s2.0-33646041638 10.1016/j.jacc.2005.10.066
6. Rothenburger M., Markewitz A., Lenz T., Kaulbach H.-G., Marohl K., Kuhlmann W.-D., Weinhold C., Detection of acute phase response and infection. The role of procalcitonin and C-Reactive protein. Clinical Chemistry and Laboratory Medicine 1999 37 3 275 279 2-s2.0-0032947162 10.1515/CCLM.1999.048 (Pubitemid 29209741)
7. Jullienne A., Segond N., Calmettes C., Biosynthesis of human calcitonin: evidence for a prohormone. Biochemical and Biophysical Research Communications 1980 95 3 932 937 2-s2.0-0019306734 (Pubitemid 10017382)
8. Zaidi M., Alam A. S., Shankar V. S., Bax B. E., Moonga B. S., Bevis P. J. R., Pazianas M., Huang C. L.-H., A quantitative description of components of in vitro morphometric change in the rat osteoclast model: relationships with cellular function. European Biophysics Journal 1992 21 5 349 355 2-s2.0-0026621712 (Pubitemid 23010570)
9. Snider R. H. Jr., Nylen E. S., Becker K. L., Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. Journal of Investigative Medicine 1997 45 9 552 560 2-s2.0-0031302675 (Pubitemid 127806489)
10. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C., High serum procalcitonin concentrations in patients with sepsis and infection. The Lancet 1993 341 8844 515 518 2-s2.0-0027466275 10.1016/0140-6736(93)90277-N (Pubitemid 23066085)
11. Carsin H., Assicot M., Feger F., Roy O., Pennacino I., Le Bever H., Ainaud P., Bohuon C., Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF α and endotoxin levels early after thermal injury. Burns 1997 23 3 218 224 2-s2.0-0030791838 10.1016/S0305-4179(96)00124-6 (Pubitemid 27303043)
12. Wanner G. A., Keel M., Steckholzer U., Beier W., Stocker R., Ertel W., Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Critical Care Medicine 2000 28 4 950 957 2-s2.0-0034098233 (Pubitemid 30262061)
13. Meisner M., Tschaikowsky K., Hutzler A., Schick C., Schüttler J., Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Medicine 1998 24 7 680 684 2-s2.0-0031822857 10.1007/s001340050644 (Pubitemid 28393399)
14. DeLee J. G., Charnley J., Radiological demarcation of cemented sockets in total hip replacement. Clinical Orthopaedics and Related Research 1976 121 20 32 2-s2.0-0017047304 (Pubitemid 8003188)
15. Gruen T. A., McNeice G. M., Amstutz H. C., "Modes of failure" of cemented stem-type femoral components. A radiographic analysis of loosening. Clinical Orthopaedics and Related Research 1979 141 17 27 2-s2.0-0018687995 (Pubitemid 10233166)
16. Engh C. A., Glassman A. H., Suthers K. E., The case for porous-coated hip implants: the femoral side. Clinical Orthopaedics and Related Research 1990 261 63 81 2-s2.0-0025695691
17. Dupont C., Rodenbach J., Flachaire E., The value of C-reactive protein for postoperative monitoring of lower limb arthroplasty. Annales de Readaptation et de Medecine Physique 2008 51 5 348 357 2-s2.0-46949106898 10.1016/j.annrmp.2008.01.014
18. Niskanen R. O., Korkala O., Pammo H., Serum C-reactive protein levels after total hip and knee arthroplasty. Journal of Bone and Joint Surgery B 1996 78 3 431 433 2-s2.0-0029891153 (Pubitemid 26158833)
19. Sedlář M., Kudrnová Z., Trča S., Mazoch J., Malíková I., Kvasnička J., Krška Z., Zeman M., Linhart A., Inflammatory response in patients undergoing hip surgery due to osteoarthrosis or different types of hip fractures. Osteoarthritis and Cartilage 2008 16 1 26 33 2-s2.0-38349185530 10.1016/j.joca.2007.05.023
20. Ghanem E., Antoci V. Jr., Pulido L., Joshi A., Hozack W., Parvizi J., The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. International Journal of Infectious Diseases 2009 13 6 e444 e449 2-s2.0-70350573524 10.1016/j.ijid.2009. 02.017
21. del Pozo J. L., Patel R., Infection associated with prosthetic joints. New England Journal of Medicine 2009 361 8 787 794 2-s2.0-69049111833 10.1056/NEJMcp0905029
22. Becker K. L., Snider R., Nylen E. S., Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. British Journal of Pharmacology 2010 159 2 253 264 2-s2.0-75649119976 10.1111/j.1476-5381.2009.00433.x
23. Chirouze C., Schuhmacher H., Rabaud C., Gil H., Khayat N., Estavoyer J.-M., May T., Hoen B., Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clinical Infectious Diseases 2002 35 2 156 161 2-s2.0-0037100303 10.1086/341023 (Pubitemid 34753900)
24. Bottner F., Wegner A., Winkelmann W., Becker K., Erren M., Götze C., Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. Journal of Bone and Joint Surgery B 2007 89 1 94 99 2-s2.0-33846879412 10.1302/0301-620X.89B1.17485 (Pubitemid 46218420)
25. Meisner M., Rauschmayer C., Schmidt J., Feyrer R., Cesnjevar R., Bredle D., Tschaikowsky K., Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Medicine 2002 28 8 1094 1102 2-s2.0-0036373064 10.1007/s00134-002-1392-5 (Pubitemid 34985233)
26. Chevillotte C. J., Ali M. H., Trousdale R. T., Larson D. R., Gullerud R. E., Berry D. J., Inflammatory laboratory markers in periprosthetic hip fractures. Journal of Arthroplasty 2009 24 5 722 727 2-s2.0-67650770052 10.1016/j.arth.2008.05.026
27. Fottner A., Birkenmaier C., von Schulze Pellengahr C., Wegener B., Jansson V., Can Serum Procalcitonin Help to Differentiate Between Septic and Nonseptic Arthritis? Arthroscopy 2008 24 2 229 233 2-s2.0-38549172231 10.1016/j.arthro.2007.07.029 (Pubitemid 351163019)
28. Hunziker S., Hügle T., Schuchardt K., Groeschl I., Schuetz P., Mueller B., Dick W., Eriksson U., Trampuz A., The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. Journal of Bone and Joint Surgery A 2010 92 1 138 148 2-s2.0-73949117001 10.2106/JBJS.H.01600
29. Sponholz C., Sakr Y., Reinhart K., Brunkhorst F., Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Critical Care 2006 10 5, article R145 2-s2.0-34447567903 10.1186/cc5067 (Pubitemid 47086948)
30. Uçkay I., Garzoni C., Ferry T., Harbarth S., Stern R., Assal M., Hoffmeyer P., Lew D., Bernard L., Postoperative serum pro-calcitonin and C-reactive protein levels in patients with orthopedic infections. Swiss Medical Weekly 2010 140 w13124 10.4414/smw.2010.13124 2-s2.0-79952202359
31. Boussekey N., Leroy O., Georges H., Devos P., D'Escrivan T., Guery B., Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 2005 33 4 257 263 2-s2.0-23844548733 10.1007/s15010-005-4096-2 (Pubitemid 41152186)